The DOI matches its Crossref record; 152 of the 154 references it cites were found in a registry or an index.
The Effects of Amiodarone on the Thyroid*
Abstract
Amiodarone is a benzofuranic-derivative iodine-rich drug widely used for the treatment of tachyarrhythmias and, to a lesser extent, of ischemic heart disease. It often causes changes in thyroid function tests (typically an increase in serum T(4) and rT(3), and a decrease in serum T(3), concentrations), mainly related to the inhibition of 5'-deiodinase activity, resulting in a decrease in the generation of T(3) from T(4) and a decrease in the clearance of rT(3). In 14-18% of amiodarone-treated patients, there is overt thyroid dysfunction, either amiodarone-induced thyrotoxicosis (AIT) or amiodarone-induced hypothyroidism (AIH). Both AIT and AIH may develop either in apparently normal thyroid glands or in glands with preexisting, clinically silent abnormalities. Preexisting Hashimoto's thyroiditis is a definite risk factor for the occurrence of AIH. The pathogenesis of iodine-induced AIH is related to a failure to escape from the acute Wolff-Chaikoff effect due to defects in thyroid hormonogenesis, and, in patients with positive thyroid autoantibody tests, to concomitant Hashimoto's thyroiditis. AIT is primarily related to excess iodine-induced thyroid hormone synthesis in an abnormal thyroid gland (type I AIT) or to amiodarone-related destructive thyroiditis (type II AIT), but mixed forms frequently exist. Treatment of AIH consists of L-T(4) replacement while continuing amiodarone therapy; alternatively, if feasible, amiodarone can be discontinued, especially in the absence of thyroid abnormalities, and the natural course toward euthyroidism can be accelerated by a short course of potassium perchlorate treatment. In type I AIT the main medical treatment consists of the simultaneous administration of thionamides and potassium perchlorate, while in type II AIT, glucocorticoids are the most useful therapeutic option. Mixed forms are best treated with a combination of thionamides, potassium perchlorate, and glucocorticoids. Radioiodine therapy is usually not feasible due to the low thyroidal radioiodine uptake, while thyroidectomy can be performed in cases resistant to medical therapy, with a slightly increased surgical risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amiodarone in Patients with Congestive Heart Failure and Asymptomatic Ventricular Arrhythmia
Singh, S. N., Fletcher, R. D., Fisher, S. G., Singh, B. N., Lewis, H. D., Deedwania, P. C., Massie, B. M., Colling, C., & Lazzeri, D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507133330201 · Cited by 1,225
Amiodarone to Prevent Recurrence of Atrial Fibrillation
Roy, D., Talajic, M., Dorian, P., Connolly, S., Eisenberg, M. J., Green, M., Kus, T., Lambert, J., Dubuc, M., Gagné, P., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421302 · Cited by 1,143
Randomised trial of low-dose amiodarone in severe congestive heart failure
Doval, H., Nul, D., Grancelli, H., Perrone, S., Bortman, G., & Curiel, R. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91895-3 · Cited by 920
Amiodarone for Resuscitation after Out-of-Hospital Cardiac Arrest Due to Ventricular Fibrillation
Kudenchuk, P. J., Cobb, L. A., Copass, M. K., Cummins, R. O., Doherty, A. M., Fahrenbruch, C. E., Hallstrom, A. P., Murray, W. A., Olsufka, M., & Walsh, T. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411203 · Cited by 809
Perchlorate and the Thyroid Gland
Wolff, J. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01350-4 · Cited by 588
Preoperative Amiodarone as Prophylaxis against Atrial Fibrillation after Heart Surgery
Daoud, E. G., Strickberger, S. A., Man, K. C., Goyal, R., Deeb, G. M., Bolling, S. F., Pagani, F. D., Bitar, C., Meissner, M. D., & Morady, F. (1997) · New England Journal of Medicine · doi:10.1056/nejm199712183372501 · Cited by 529
Holt, D. W., Tucker, G. T., Jackson, P. R., & Storey, G. C. A. (1983) · American Heart Journal · doi:10.1016/0002-8703(83)90006-6 · Cited by 410
Environmental Iodine Intake and Thyroid Dysfunction During Chronic Amiodarone Therapy
MARTINO, E., SAFRAN, M., AGHINI-LOMBARDI, F., RAJATANAVIN, R., LENZIARDI, M., FAY, M., PACCHIAROTTI, A., ARONIN, N., MACCHIA, E., HAFFAJEE, C., et al. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-1-28 · Cited by 370
Self-citationPhosphofructokinase deficiency in skeletal muscle. A new type of glycogenosis
Tarui, S., Giichi, O., Ikura, Y., Tanaka, T., Suda, M., & Nishikawa, M. (1965) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(65)90156-7 · Cited by 369
Burger, A., Dinichert, D., Nicod, P., Jenny, M., Lemarchand-Béraud, T., & Vallotton, M. B. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108466 · Cited by 312
Cited by
Items 201–300 of 615
Eder, S., Hermann, C., Lamkowski, A., Kinoshita, M., Yamamoto, T., Abend, M., Shinomiya, N., Port, M., & Rump, A. F. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02809-z · Cited by 19
Berti, P., Materazzi, G., Bogazzi, F., Ambrosini, C. E., Martino, E., & Miccoli, P. (2006) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-006-0112-y · Cited by 19
Self-citationAmiodarone-induced thyroid dysfunction in a tertiary center in south Brazil
Schaan, B. D., da Cunha, C. P., Francisconi, A., Zottis, B., Brum, G., Brüch, R. S., & Gus, M. (2005) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302005000600010 · Cited by 19
Enfermedad tiroidea subclínica: revisión y enfoque clínico
Liberman, G. C. (2013) · Revista Médica Clínica Las Condes · doi:10.1016/s0716-8640(13)70219-0 · Cited by 19
Evaluation of Endocrine Function
Guber, H. A., & Farag, A. F. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0974-2.00024-5 · Cited by 19
Yang, X. F., Xu, J., Guo, H. L., Hou, X. H., Li, H., Liu, L. G., & Sun, X. F. (2007) · British Journal Of Nutrition · doi:10.1017/s0007114507691909 · Cited by 19
Drugs and Other Substances Interfering with Thyroid Function
Montanelli, L., Benvenga, S., Hegedüs, L., Vitti, P., Latrofa, F., & Duntas, L. H. (2018) · Endocrinology · doi:10.1007/978-3-319-45013-1_27 · Cited by 18
Singh, A., Riaz, R., Verma, A., Irfan, H., Shaukat, A. F., Nadeem, A., Goyal, P., Habib, A., & Satapathy, P. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000003391 · Cited by 18
Cappellani, D., Marconcini, G., Manetti, L., Bartalena, L., & Bogazzi, F. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac756 · Cited by 18
Self-citationThyroid Disorders and Prognosis in Chronic Heart Failure: A Long-Term Follow-Up Study
Iacoviello, M., Parisi, G., Gioia, M. I., Grande, D., Rizzo, C., Guida, P., Lisi, F., Giagulli, V. A., Licchelli, B., Serio, F. D., et al. (2019) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530319666191018134524 · Cited by 18
Darias-Rosales, J., Rubio, C., Gutiérrez, A. J., Paz, S., & Hardisson, A. (2020) · Environmental Science and Pollution Research · doi:10.1007/s11356-020-10478-9 · Cited by 18
Klinische Besonderheiten der Therapie mit Amiodaron
Haverkamp, W., Israel, C. W., & Parwani, A. S. (2017) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-017-0516-0 · Cited by 18
An update on the pharmacological management of hyperthyroidism due to Graves’ disease
Bartalena, L., Tanda, M. L., Bogazzi, F., Piantanida, E., Lai, A., & Martino, E. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.6.851 · Cited by 18
Self-citationThyrotoxicosis of other Etiologies
Kopp, P. A. (2010) · Cited by 18
Omidi, N., Khorgami, M., Tajrishi, F. Z., Seyedhoseinpour, A., & Pasbakhsh, P. (2019) · Current Cardiology Reviews · doi:10.2174/1573403x15666191008111238 · Cited by 17
Yamazaki, K., Mitsuhashi, T., Yamada, E., Yamada, T., Kosaka, S., Takano, K., Obara, T., & Sato, K. (2007) · Thyroid · doi:10.1089/thy.2007.0215 · Cited by 17
Approach to a low TSH level: patience is a virtue
Pantalone, K. M., & Nasr, C. (2010) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.77a.10056 · Cited by 16
Elmenyar, E., Aoun, S., Saadi, Z. A., Barkumi, A., Cander, B., Al-Thani, H. A. S., & El-Menyar, A. A. (2023) · Diagnostics · doi:10.3390/diagnostics13193028 · Cited by 16
Diamanti‐Kandarakis, E., Duntas, L. H., Kanakis, G., Kandaraki, E., Karavitaki, N., Kassi, E. N., Livadas, S., Mastorakos, G. P., Migdalis, I. N., Miras, A. D., et al. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0154 · Cited by 16
Cappellani, D., Marco, G. D., Ferrarini, E., Torregrossa, L., Certo, A. M. D., Cosentino, G., Urbani, C., Marconcini, G., Mattiello, A., Manetti, L., et al. (2021) · Thyroid · doi:10.1089/thy.2021.0118 · Cited by 16
Self-citationDietary iodine intake in the Chinese population.
Sui, H., Li, J. W., Mao, W. F., Zhu, J. H., He, Y. N., Song, X. Y., Ma, N., Zhang, L., Liu, S. N., Liu, Z. P., et al. (2011) · PubMed · doi:10.3967/0895-3988.2011.06.005 · Cited by 16
Management of amiodarone-induced thyrotoxicosis
Younis, N., El-Houni, A., Soran, H., & Jones, I. R. (2002) · Hospital Medicine · doi:10.12968/hosp.2002.63.9.1951 · Cited by 16
Pavan, R., Jesus, A. M. X., & Maciel, L. M. Z. (2004) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302004000100020 · Cited by 16
The Thyroid Pathologist Meets Therapeutic Pharmacology
Sande, C. M., Resta, I. T., & LiVolsi, V. A. (2023) · Endocrine Pathology · doi:10.1007/s12022-023-09749-1 · Cited by 15
Use of glucocorticoids in amiodarone-induced thyrotoxicosis
Vanderpump, M. P. J. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.218 · Cited by 15
Latrofa, F., & Pinchera, A. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-517-6_7 · Cited by 15
Duron, F., Dubosclard, E., Ballot, E., & Johanet, C. (2004) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(04)74266-3 · Cited by 15
Bogazzi, F., Bartalena, L., Tomisti, L., Dell'Unto, E., Cosci, C., Sardella, C., Tanda, M. L., Lai, A., Gasperi, M., Aghini-Lombardi, F., et al. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03346400 · Cited by 15
Self-citationAvery, A. J., Rodgers, S., Cantrill, J. A., Armstrong, S. L., Boyd, M., Cresswell, K. M., Eden, M., Elliott, R. A., Franklin, M. K., Hippisley‐Cox, J., et al. (2010) · CentAUR (University of Reading) · Cited by 15
Influence ofCYP2C8*13andCYP2C8*14Alleles on AmiodaroneN‐Deethylation
Hanioka, N., Matsumoto, K., Saito, Y., & Narimatsu, S. (2011) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2010.00669.x · Cited by 14
Dysthyroidism and Chronic Heart Failure: Pathophysiological Mechanisms and Therapeutic Approaches
Rizzo, C., Gioia, M. I., Parisi, G., Triggiani, V., & Iacoviello, M. (2017) · Advances in experimental medicine and biology · doi:10.1007/5584_2017_132 · Cited by 14
Cappellani, D., Urbani, C., Manetti, L., Martino, E., Bartalena, L., & Bogazzi, F. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01252-2 · Cited by 14
Self-citationYamato, M., Wada, K., Hayashi, T., Fujimoto, M., Hosomi, K., Oita, A., & Takada, M. (2017) · Clinical Drug Investigation · doi:10.1007/s40261-017-0582-4 · Cited by 14
Aleksić, Ž., Aleksić, A., & Đorđević, B. (2022) · Timocki medicinski glasnik · doi:10.5937/tmg2201011a · Cited by 14
Massart, F., Harrell, J. C., Federico, G., & Saggese, G. (2007) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2006.09.024 · Cited by 14
Prevention of postoperative atrial fibrillation in cardiac surgery: a quality improvement project
Egan, S., Collins‐Smyth, C., Chitnis, S., Head, J., Chiu, A., Bhatti, G., & McLean, S. R. (2023) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-023-02619-8 · Cited by 13
Patel, N., Inder, W. J., Sullivan, C. M., & Kaye, G. (2014) · Heart Lung and Circulation · doi:10.1016/j.hlc.2014.01.013 · Cited by 13
Does Iodine Excess Lead to Hypothyroidism? Evidence from a Case-Control Study in India
Kotwal, A., Kotwal, J., Prakash, R., & Kotwal, N. (2015) · Archives of Medical Research · doi:10.1016/j.arcmed.2015.07.005 · Cited by 13
Silva, J. R., Guariento, M. E., Fernandes, G. A., Maciel, R. M. B., & Ward, L. S. (2004) · Thyroid · doi:10.1089/105072504774193212 · Cited by 13
Le symporteur sodium/iodure : données récentes et perspectives thérapeutiques
Plantin-Carrenard, E., Foglietti, M. J., & Beaudeux, J. (2004) · Pathologie Biologie · doi:10.1016/j.patbio.2004.06.003 · Cited by 13
Mazzaferri, E. L. (2006) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(08)70361-5 · Cited by 13
Combination of Rivaroxaban and Amiodarone Increases Bleeding in Patients With Atrial Fibrillation
Wang, Z., Li, X., Zou, Y., Li, X., & Lv, Q. (2023) · Annals of Pharmacotherapy · doi:10.1177/10600280231211306 · Cited by 12
Grineva, E. N., Tsoy, U. A., Karonova, T. L., Andreychenko, T. V., Богданова, Г. А., Vanushko, V. E., Dalmatova, A. B., Данилов, И. Н., Иваниха, E. В., Lebedev, D. S., et al. (2021) · Clinical and experimental thyroidology · doi:10.14341/ket12693 · Cited by 12
Amiodarone-Induced Thyrotoxic Thyroiditis: A Diagnostic and Therapeutic Challenge
Barvalia, U., Amlani, B., & Pathak, R. D. (2014) · Case Reports in Medicine · doi:10.1155/2014/231651 · Cited by 12
Association between N-desethylamiodarone/amiodarone ratio and amiodarone-induced thyroid dysfunction
Yamato, M., Wada, K., Fujimoto, M., Hosomi, K., Hayashi, T., Oita, A., & Takada, M. (2017) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-017-2195-5 · Cited by 12
Hashimoto, K., Ota, M., Irie, T., Takata, D., Nakajima, T., Kaneko, Y., Tanaka, Y., Matsumoto, S., Nakajima, Y., Kurabayashi, M., et al. (2015) · Case Reports in Endocrinology · doi:10.1155/2015/416145 · Cited by 12
Kimura, H., Kato, Y., Shimizu, S., Takano, K., & Sato, K. (2009) · Thyroid · doi:10.1089/thy.2009.0066 · Cited by 12
Incidence of amiodarone-induced thyroid dysfunction and predictive factors for their occurrence
Aleksić, Ž., & Aleksic, A. (2011) · Medicinski pregled · doi:10.2298/mpns1112533a · Cited by 12
Electrosprayed 4-carboxybenzenesulfonamide-chitosan microspheres for acetazolamide delivery
Suvannasara, P., Siralertmukul, K., & Muangsin, N. (2013) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2013.12.012 · Cited by 12
Chronic (Hashimoto's) Thyroiditis
Lazarus, J. H. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00083-6 · Cited by 12
Oki, G. C. R., Zantut‐Wittmann, D. E., Santos, A. O., Guariento, M. H., Tambascia, M. A., de Almeida, E. A., Amorim, B. J., Lima, M., Etchebehere, E., Camargo, E. E., et al. (2010) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e3181d18e8e · Cited by 12
Hipertiroidismo inducido por consumo de algas marinas
Salas-Coronas, J., Caparrós, G. C., Bretones, F. L., & Díez García, F. (2002) · Medicina Clínica · doi:10.1016/s0025-7753(02)72534-7 · Cited by 12
Francisca Brusco, G., González, G., V, Néstor Soto, I., & Arteaga, E. (2004) · Thyroid · doi:10.1089/thy.2004.14.862 · Cited by 12
Siccama, R., Balk, A. H. M. M., de Herder, W. W., van Domburg, R., Vantrimpont, P. J. M. J., & van Gelder, T. (2003) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(02)01149-x · Cited by 12
Gheri, R. G., Pucci, P., FALSETTI, C., Luisi, M., Cerisano, G., Gheri, C. F., Petruzzi, I., Pinzani, P., Salvadori, B., & Petruzzi, E. (2003) · Archives of Gerontology and Geriatrics · doi:10.1016/s0167-4943(03)00080-3 · Cited by 12
Effects of chronic amiodarone treatment on rat testis
Özkaya, A. K., Dilber, E., Gürgen, S. G., Kutlu, Ö., Cansu, A., & Gedik, Y. (2016) · Acta Histochemica · doi:10.1016/j.acthis.2016.02.003 · Cited by 12
Rabkin, S. W. (2006) · Pharmacology · doi:10.1159/000090725 · Cited by 12
Repercusiones del tratamiento con amiodarona sobre la función tiroidea y su manejo actual
Iglesias, P. (2007) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(07)71465-1 · Cited by 12
Thyroid Disorders in Children and Adolescents
Rivkees, S. A., & Bauer, A. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00013-0 · Cited by 11
Managing thyroid dysfunction in selected special situations
Sabih, D. E., & Inayatullah, M. (2013) · Thyroid Research · doi:10.1186/1756-6614-6-2 · Cited by 11
Laboratory evaluation of thyroid function: Dilemmas and pitfalls
Kumar, K. V. S. H., Garg, M., & Mahalle, N. P. (2016) · Medical Journal of Dr D Y Patil University · doi:10.4103/0975-2870.186054 · Cited by 11
Schmid, K. W., & Sheu‐Grabellus, S. (2015) · Springer eBooks · doi:10.1007/978-3-642-04566-0_19 · Cited by 11
Nakagawa, J., Fujikawa, K., Akagi, M., Nakaji, K., Yasui, J., Hanatani, Y., Hara, T., Mizokami, A., & Kawakami, A. (2020) · Modern Rheumatology Case Reports · doi:10.1080/24725625.2020.1741116 · Cited by 10
Amiodarone-induced type 2 thyrotoxicosis
Portelli, D., Mifsud, S., Abela, A. G., & Fava, S. (2021) · BMJ Case Reports · doi:10.1136/bcr-2020-238145 · Cited by 10
Schreiber, D. H., & DeFreest, M. (2006) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2005.08.011 · Cited by 10
Impact of endocrine-disrupting chemicals on thyroid function and brain development
Ibhazehiebo, K., & Koibuchi, N. (2014) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2014.950227 · Cited by 10
Wang, M., Cai, S., Sun, L., Zhao, Q., & Feng, W. (2016) · Cardiology Journal · doi:10.5603/cj.a2016.0029 · Cited by 10
Amiodarone-induced thyrotoxicosis: type 1 or type 2?
Khan, A. U., Puttanna, A., & Raskauskiene, D. (2014) · BMJ Case Reports · doi:10.1136/bcr-2014-204485 · Cited by 10
Chronic (Hashimoto’s) Thyroiditis
Amino, N., Lazarus, J. H., & DeGroot, L. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00086-x · Cited by 10
Amiodarone-induced Hypothyroidism with EPO-resistant Anemia in a Patient with Chronic Renal Failure
Chang, P. M. S., & Ng, Y. (2008) · Journal of the Chinese Medical Association · doi:10.1016/s1726-4901(08)70172-2 · Cited by 10
Mackie, G. C., & Shulkin, B. L. (2005) · Thyroid · doi:10.1089/thy.2005.15.1337 · Cited by 10
Song, Y., Guo, T., Jiang, Y., Zhu, M., Wang, H., Lu, W., Jiang, M., Qi, M., Lan, F., & Cui, M. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02964-3 · Cited by 9
Wolmarans, D. W. (2017) · South African Family Practice · doi:10.4102/safp.v59i4.4723 · Cited by 9
Case Series: Minocycline-Associated Thyroiditis
Millington, K., Charrow, A. P., & Smith, J. R. (2019) · Hormone Research in Paediatrics · doi:10.1159/000502843 · Cited by 9
Amiodarone bioconcentration and suppression of metamorphosis in Xenopus
Sanoh, S., Hanada, H., Kashiwagi, K., Mori, T., Goto‐Inoue, N., Suzuki, K., Mori, J., Nakamura, N., Yamamoto, T., Kitamura, S., et al. (2020) · Aquatic Toxicology · doi:10.1016/j.aquatox.2020.105623 · Cited by 9
Thyroid scintigraphy in the era of fine‐needle aspiration cytology
Pirola, I., Lodovico, E. D., Casella, C., Pezzaioli, L. C., Facondo, P., Ferlin, A., Lombardi, D., & Cappelli, C. (2020) · Clinical Endocrinology · doi:10.1111/cen.14379 · Cited by 9
Total Thyroidectomy for Medically Refractory Amiodarone-Induced Thyrotoxicosis
Mehta, A. N., Vallera, R. D., Tate, C. R., Sager, R., & Welch, B. J. (2008) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2008.11928432 · Cited by 9
Kaiser, P., Hoess, C., Krause, M., & Pavlicek, V. (2008) · Swiss Medical Forum ‒ Schweizerisches Medizin-Forum · doi:10.4414/smf.2008.06622 · Cited by 9
Enjeux liés à l’hyperthyroïdie induite par l’amiodarone
Tauveron, I., Batisse‐Lignier, M., & Maqdasy, S. (2018) · La Presse Médicale · doi:10.1016/j.lpm.2018.09.001 · Cited by 8
Bračko, S., & Čelofiga, A. (2024) · Archives of Psychiatry Research · doi:10.20471/feb.2024.60.01.08 · Cited by 8
Laplano, N. E. R., & MERCADO-ASIS, L. B. (2012) · Intern J Endocrinol Metab · doi:10.5812/ijem.5406 · Cited by 8
Yamamoto, J. M., Katz, P. M., Bras, J. A. F., Shafer, L. A., Leung, A. A. C., Ravandi, A., & Cordova, F. J. (2018) · Health Science Reports · doi:10.1002/hsr2.36 · Cited by 8
Markantes, G. Κ., Michalaki, M. A., Vagenakis, G. A., Lamari, F. N., Pitsi, E., Ηλιοπούλου, Μ., Beratis, N. G., & Markou, K. B. (2019) · European Thyroid Journal · doi:10.1159/000500355 · Cited by 8
Smith, P. W., Salomone, L. J., & Hanks, J. B. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1560-6.00038-x · Cited by 8
Amiodarona e tireotoxicose: relatos de casos
Tavares, A. B. W., de Paula, S. K., Vaisman, M., & Teixeira, P. D. F. D. S. (2010) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2010001500022 · Cited by 8
Uptake of amiodarone by thyroidal and non-thyroidal cell lines
Bogazzi, F., Raggi, F., Ultimieri, F., Russo, D., Cosci, C., Cecchetti, P., Dell'Unto, E., Sardella, C., Tonacchera, M., Vitti, P., et al. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03349178 · Cited by 8
Self-citationEffects of amiodarone on thyroid function
Kahandawa, S., & Somasundaram, N. P. (2012) · Sri Lanka Journal of Diabetes Endocrinology and Metabolism · doi:10.4038/sjdem.v1i1.4185 · Cited by 8
Therapiebedingte Veränderungen der Schilddrüse
Sheu, S., Levin, S., & Schmid, K. W. (2006) · Der Pathologe · doi:10.1007/s00292-005-0813-y · Cited by 8
Disfunção tireoidiana e conduta dos cardiologistas em pacientes usando amiodarona
Fuks, A. G., Vaisman, M., & Buescu, A. (2004) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2004000600005 · Cited by 8
Brian, S. R., Cheng, D. W., & Goldberg, P. A. (2007) · Endocrine Practice · doi:10.4158/ep.13.4.413 · Cited by 8
Amiodarone-induced thyroiditis
Goichot, B., Grünenberger, F., & Schlienger, J. L. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09271-1 · Cited by 8
The Therapeutic Potential of Propranolol and Other Beta-Blockers in Hyperthyroidism
Szybiak, W., Miedziaszczyk, M., Szałek, E., & Łącka, K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178322 · Cited by 7
Zugravu, C., Petre, M., & Constantin, C. (2026) · Geriatrics · doi:10.3390/geriatrics11010012 · Cited by 7
Amiodarone-induced thyrotoxicosis: Should surgery be considered?
Frey, S., Caillard, C., Mahot, P., Drui, D., & Mirallié, É. (2024) · Annales d Endocrinologie · doi:10.1016/j.ando.2024.01.006 · Cited by 7
Yang, J., You, M., Wang, J., Sun, R., Han, L., Liu, X., Niu, K., Xing, K., Sun, J., Su, W., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1517616 · Cited by 7
Cai, Y., Li, X., Yang, P., Chen, J., Lu, J., Chovelon, J., & Ji, Y. (2025) · Water Research · doi:10.1016/j.watres.2025.123705 · Cited by 7
Sugiyama, K., Kobayashi, S., Kurihara, I., Miyashita, K., Yokota, K., Kohno, T., Noh, J. Y., & Itoh, H. (2020) · Endocrine Journal · doi:10.1507/endocrj.ej20-0307 · Cited by 7
Thyroïdites : où en est-on en 2019 ?
Rouland, A., Buffier, P., Petit, J.-M., Vergès, B. L., & Bouillet, B. (2020) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2020.02.003 · Cited by 7
Trawiński, J., & Skibiński, R. (2021) · Chemosphere · doi:10.1016/j.chemosphere.2021.133420 · Cited by 7
[Amiodarone effects on thyroid--current concepts].
Campos, M. V. (2004) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.20344/amp.1081 · Cited by 7
Metadata
- Authors
- Martino, E., Bartalena, L., Bogazzi, F., & Braverman, L. E.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2001-04-01
- Volume
- 22
- Issue
- 2
- Pages
- 240-254
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2117317136
- Cited by
- 551
- References
- 154
- FWCI
- 14.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.